Annie Aesthetic Holdings LLC

Annie Aesthetic Holdings is a U. S. -based medical aesthetics group that partners with and acquires clinics to enhance operational efficiency and growth through strategic support and advanced technology solutions. Founded in 2022, Annie Aesthetic Holdings operates as a medical aesthetics group, focusing on acquiring reputable clinics across the United States.

In September 2025, Annie Aesthetic Holdings LLC raised an undisclosed amount in series B funding led by returning investor InterAlpen Partners, with participation from another returning investor Plexus Capital. New investor Brookside Equity Partners also participated in the round. Annie Aesthetic operates as a medical aesthetics group focused on partnering with or acquiring reputable clinics across the United States. Their core offerings include operational support, capital for growth, customer acquisition enhancement, recruiting and HR administrative support, and advanced technology implementation.

The company utilizes data and technological tools to streamline operations and improve compliance, licensing, and regulatory efforts for their partner clinics. By doing so, Annie Aesthetic aims to create win-win scenarios where partner clinics can achieve their personal and professional goals, enabling them to thrive in a competitive marketplace. The primary client base consists of medical aesthetics clinics seeking to optimize their operations and expand their service offerings, with a geographical focus spanning various states in the U. S.

, particularly those with burgeoning aesthetic markets. Annie Aesthetic generates revenue through strategic partnerships and acquisitions of medical aesthetics clinics, structured around a range of transaction models. Their financial arrangements include options for full cash payouts, partial cash outs, or rolling ownership interests, thereby accommodating the varying needs of clinic owners. For instance, a clinic owner might choose to engage in a partnership where they receive 60-90% of the transaction in cash while retaining a 10-40% stake in the business, allowing them to benefit from future valuations.

The company's revenue is also bolstered by offering operational and marketing support, thereby creating additional revenue channels through enhanced clinic performance. Overall, their revenue model reflects a commitment to transparency and collaboration, positioning them as a reliable partner in the medical aesthetics industry.